Dr. Eric Reiman and Dr. Adam Fleisher of Banner Alzheimer’s Institute speak with CBS Sunday Morning about their research work and the hope that one family in Colombia is giving to Alzheimer’s patients all over the world. Click here to view the original article
CONTINUE READING9/18/13 PHOENIX - In collaboration with the National Institutes of Health (NIH), Banner Alzheimer’s Institute (BAI) announces a major prevention trial to evaluate a treatment in cognitively healthy older adults at the highest known genetic risk for developing Alzheimer’s disease at older ages. An NIH grant, expected to total $33.2 million, will support this research. Read the […]
CONTINUE READING9/18/13 PHOENIX - Recognizing the need to accelerate research to prevent Alzheimer’s disease and engage consumers, Banner Alzheimer’s Institute (BAI) announced a major multi-corporation partnership today. The Global CEO Initiative on Alzheimer’s disease (CEOi) and many of its member companies including: Bank of America, GE Healthcare, Janssen Research and Development, LLC., and Merck will partner together […]
CONTINUE READING1/24/2013 SAN DIEGO – The American Academy of Neurology and the American Brain Foundation are awarding the 2013 Potamkin Prize for Research in Pick’s, Alzheimer’s and Related Diseases to William J. Jagust, MD, with the University of California, Berkeley, Michael W. Weiner, MD, with the San Francisco VA Medical Center in San Francisco and Eric […]
CONTINUE READING2/4/2013 State-of-the-art center to foster the continuation of pioneering imaging research PHOENIX, Ariz. (Feb. 5, 2013) – The opening of a $16.3 million state-of-the-art Imaging Center further cements the internationally-recognized work occurring at Banner Alzheimer’s Institute (BAI) and advances statewide collaboration in Alzheimer’s disease and other neuroscientific, cardiology and oncology research. Read the press release […]
CONTINUE READING2/21/2013 Arizona State University and Mayo Clinic have awarded two $100,000 grants to collaborative research teams working on precision medicine to treat Alzheimer’s disease and cerebral aneurysms. This award competition comes at a time when ASU and Mayo continue to deepen their partnership working in conjunction to expand Mayo’s medical school to the Phoenix area. […]
CONTINUE READING3/20/2013 New class of small molecules show promise against memory loss TUCSON, Ariz. — March 20, 2013 — BIO5 Oro Valley today announced a collaboration with the Translational Genomics Research Institute (TGen) to develop new therapies for the treatment of Alzheimer’s and other neurodegenerative diseases. Read the press release here. (Link will open in a […]
CONTINUE READING5/3/2013 About 5 percent of men and women, ages 65 to 74, have Alzheimer’s disease, and it is estimated that nearly half of those age 85 and older may have the disease. Among known risks are age and genetics. Read the press release here. (Link will open in a new window)
CONTINUE READING5/21/2013 AZ Central peers into the mind of an Alzheimer’s researcher Into the mind of … Matt Huentelman The TGen researcher explains why he’s using crowd- sourcing to better understand Alzheimer’s disease. Read the article here. (Link will open in a new window)
CONTINUE READING